Chinese Co. To Pay $2.2M To End Vitamin C Antitrust Case

Law360, New York (December 16, 2013, 7:31 PM EST) -- Weisheng Pharmaceutical Co. Ltd. and parent company CSPC Pharmaceutical Group Ltd., formerly known as China Pharmaceutical Group Ltd., have agreed to pay $2.2 million to settle with consumers and other indirect purchasers over claims that they conspired to fix vitamin C prices, the plaintiffs said Friday.

The indirect purchaser plaintiffs moved for preliminary approval of the deal, which leaves only Hebei Welcome Pharmaceutical Co. Ltd. fighting the antitrust case.

"Settlement talks with Weisheng and CSPC ... began in summer of 2013, and underwent several rounds of...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

In Re Vitamin C Antitrust Litigation


Case Number

1:06-md-01738

Court

New York Eastern

Nature of Suit

Anti-Trust

Judge

Brian M. Cogan

Date Filed

February 22, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.